Moneycontrol Be a Pro
Get App
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > Pharmaceuticals > Quarterly Results - AstraZeneca Pharma

AstraZeneca Pharma

BSE: 506820|NSE: ASTRAZEN|ISIN: INE203A01020|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Nov 15, 16:00
2621.80
-30.1 (-1.14%)
VOLUME 3,836
LIVE
NSE
Nov 15, 15:57
2622.85
-25.95 (-0.98%)
VOLUME 96,947
Download Annual Report PDF Format 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011

Quarterly Results of AstraZeneca Pharma

------------------- in Rs. Cr. -------------------
Sep '19 Jun '19 Mar '19 Dec '18 Sep '18
Net Sales/Income from operations 208.48 204.56 190.30 215.19 161.36
Other Operating Income -- -- -- -- --
Total Income From Operations 208.48 204.56 190.30 215.19 161.36
EXPENDITURE
Consumption of Raw Materials 13.28 18.75 22.24 16.84 9.46
Purchase of Traded Goods 63.58 46.68 80.92 41.57 27.36
Increase/Decrease in Stocks -2.71 4.61 -40.28 6.51 15.90
Power & Fuel -- -- -- -- --
Employees Cost 52.16 50.73 60.41 52.11 44.95
Depreciation 4.64 4.63 3.91 3.78 3.67
Excise Duty -- -- -- -- --
Admin. And Selling Expenses 14.01 16.98 22.98 16.51 11.68
R & D Expenses -- -- -- -- --
Provisions And Contingencies -- -- -- -- --
Exp. Capitalised -- -- -- -- --
Other Expenses 34.59 31.24 37.67 40.77 37.24
P/L Before Other Inc. , Int., Excpt. Items & Tax 28.92 30.94 2.46 37.10 11.09
Other Income 3.16 2.99 6.01 3.50 3.35
P/L Before Int., Excpt. Items & Tax 32.08 33.92 8.47 40.59 14.44
Interest 0.28 0.30 -- -- --
P/L Before Exceptional Items & Tax 31.80 33.63 8.47 40.59 14.44
Exceptional Items -- -- -- -- --
P/L Before Tax 31.80 33.63 8.47 40.59 14.44
Tax 17.38 12.11 -1.35 11.50 5.31
P/L After Tax from Ordinary Activities 14.42 21.52 9.82 29.09 9.13
Prior Year Adjustments -- -- -- -- --
Extra Ordinary Items -- -- -- -- --
Net Profit/(Loss) For the Period 14.42 21.52 9.82 29.09 9.13
Equity Share Capital 5.00 5.00 5.00 5.00 5.00
Reserves Excluding Revaluation Reserves -- -- -- -- --
Equity Dividend Rate (%) -- -- -- -- --
EPS Before Extra Ordinary
Basic EPS 5.77 8.61 3.93 11.64 3.65
Diluted EPS 5.77 8.61 3.93 11.64 3.65
EPS After Extra Ordinary
Basic EPS 5.77 8.61 3.93 11.64 3.65
Diluted EPS 5.77 8.61 3.93 11.64 3.65
Public Share Holding
No Of Shares (Crores) -- -- -- -- --
Share Holding (%) -- -- -- -- --
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores) -- -- -- -- --
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --
b) Non-encumbered
- Number of shares (Crores) -- -- -- -- --
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --
Notes
Source : Dion Global Solutions Limited

Results of AstraZeneca

  • News
  • Results
  • Estimates
  • Analysis
No news.

Results of Pharmaceuticals Sector

  • News
  • Results
  • Estimates
  • Analysis
No news.
Quick Links for astrazenecapharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.